Form D · Other
One World Pharma, Inc.
Las Vegas, NV · CIK 0001622244
Offering snapshot reported Aug 23, 2019 · SEC filing
- Reported sold
- $1.02M Offering amount: $2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 17, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 23, 2019 | Initial | $1,022,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-347240
Source: Form D, filed Aug 23, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Craig Ellins | Director, Executive, Promoter |
| Brian Moore | Executive |
| Dr. Kenneth Perego | Director |
| Bruce Raben | Director |
Issuer details
Industry: Other (See others in industry)
Address:
3471 West Oquendo Road, Suite 301
Las Vegas, NV, 89118
Las Vegas, NV, 89118